SCHEMBL25925818

SCHEMBL25925818

Oc1ccc(/N=N/c2snc3cccnc23)c(O)c1/N=N/c1ccncc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 9/20 0.42
KMT2A Q03164 9/20 0.42
MAPT P10636 7/20 0.42
TDP1 Q9NUW8 5/20 0.42
L3MBTL1 Q9Y468 5/20 0.42
HTT P42858 4/20 0.42
SMN1; SMN2 Q16637 4/20 0.42
LMNA P02545 3/20 0.42
KCNH2 Q12809 2/20 0.42
ALDH1A1 P00352 1/20 0.42
GLO1 Q04760 5/20 0.42
MAPK1 P28482 5/20 0.40
RAB9A P51151 4/20 0.40
HSP90AA1 P07900 4/20 0.40
OPRK1 P41145 4/20 0.40
ATM Q13315 2/20 0.40
KDM4E B2RXH2 2/20 0.40
RPS6KA3 P51812 1/20 0.40
NPC1 O15118 1/20 0.39
CASP6 P55212 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25925826 0.86 MEN1 (0.32) MEN1KMT2AMAPTTDP1L3MBTL1
SCHEMBL25925787 0.81 BRD4 (0.37) MEN1KMT2AMAPTTDP1L3MBTL1
SCHEMBL25925802 0.79 MAPT (0.35) MEN1KMT2AMAPTTDP1L3MBTL1
SCHEMBL14395619 0.75 MAPT (0.39) MEN1KMT2AMAPTTDP1L3MBTL1
SCHEMBL25925819 0.74 MEN1 (0.42) MEN1KMT2AMAPTTDP1L3MBTL1
SCHEMBL25925817 0.73 KMT2A (0.32) MEN1KMT2AMAPTTDP1L3MBTL1
SCHEMBL25925784 0.69
SCHEMBL25925813 0.68
SCHEMBL9475617 0.67 THRB (0.56) MEN1KMT2AMAPTTDP1L3MBTL1
SCHEMBL6813525 0.67 THRB (0.56) MEN1KMT2AMAPTTDP1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230242523-A1 COMPOUND, TAUTOMER OF COMPOUND OR SALT OF COMPOUND OR TAUTOMER, METHOD FOR PRODUCING SAME, COLORING COMPOSITION, DYEING METHOD, AND DYED ARTICLE FUJIFILM CORPORATION (JP) 2023-08-03 US disclosed
US-20230242523-A1 COMPOUND, TAUTOMER OF COMPOUND OR SALT OF COMPOUND OR TAUTOMER, METHOD FOR PRODUCING SAME, COLORING COMPOSITION, DYEING METHOD, AND DYED ARTICLE FUJIFILM CORPORATION (JP) 2023-08-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230242523-A1 COMPOUND, TAUTOMER OF COMPOUND OR SALT OF COMPOUND OR TAUTOMER, METHOD FOR PRODUCING SAME, COLORING COMPOSITION, DYEING METHOD, AND DYED ARTICLE AR, MAPT, NR5A1 MEN1 67/4885KMT2A 1814/4885MAPT 2/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.